HuGE Literature Finder
Records
1
-
2
A phase II study of a human anti-PDGFRa monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors. Annals of oncology : official journal of the European Society for Medical Oncology 2017 Mar 28 (3): 541-546. Wagner A J, Kindler H, Gelderblom H, Schöffski P, Bauer S, Hohenberger P, Kopp H-G, Lopez-Martin J A, Peeters M, Reichardt P, Qin A, Nippgen J, Ilaria R L, Rutkowski |
A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumor. Oncology 2009 Mar 76 (5): 5. Ryu MH, Kang WK, Bang YJ, Lee KH, Shin DB, Ryoo BY, Roh JK, Kang JH, Lee H, Kim TW, Chang HM, Park JO, Park YS, Kim TY, Kim MK, Lee WK, Kang HJ, Kang YK |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 29, 2023
- Content source: